| UniProt ID | CAV1_MOUSE | |
|---|---|---|
| UniProt AC | P49817 | |
| Protein Name | Caveolin-1 | |
| Gene Name | Cav1 | |
| Organism | Mus musculus (Mouse). | |
| Sequence Length | 178 | |
| Subcellular Localization |
Golgi apparatus membrane Peripheral membrane protein. Cell membrane Peripheral membrane protein. Membrane, caveola Peripheral membrane protein . Membrane raft . Golgi apparatus, trans-Golgi network . Colocalized with DPP4 in membrane rafts. Poten |
|
| Protein Description | Involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Its binding to DPP4 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. Forms a stable heterooligomeric complex with CAV2 that targets to lipid rafts and drives caveolae formation (By similarity). Recruits CTNNB1 to caveolar membranes and may regulate CTNNB1-mediated signaling through the Wnt pathway. [PubMed: 10816572 Negatively regulates TGFB1-mediated activation of SMAD2/3 by mediating the internalization of TGFBR1 from membrane rafts leading to its subsequent degradation (By similarity Mediates the recruitment of CAVIN proteins (CAVIN1/2/3/4) to the caveolae] | |
| Protein Sequence | MSGGKYVDSEGHLYTVPIREQGNIYKPNNKAMADEVTEKQVYDAHTKEIDLVNRDPKHLNDDVVKIDFEDVIAEPEGTHSFDGIWKASFTTFTVTKYWFYRLLSTIFGIPMALIWGIYFAILSFLHIWAVVPCIKSFLIEIQCISRVYSIYVHTFCDPLFEAIGKIFSNIRISTQKEI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSGGKYVDS ------CCCCCEECC | 57.14 | 26824392 | |
| 2 | Acetylation | ------MSGGKYVDS ------CCCCCEECC | 57.14 | 23806337 | |
| 5 | Acetylation | ---MSGGKYVDSEGH ---CCCCCEECCCCC | 45.70 | 23806337 | |
| 5 | Ubiquitination | ---MSGGKYVDSEGH ---CCCCCEECCCCC | 45.70 | 22790023 | |
| 6 | Phosphorylation | --MSGGKYVDSEGHL --CCCCCEECCCCCE | 16.86 | 22499769 | |
| 8 | Ubiquitination | MSGGKYVDSEGHLYT CCCCCEECCCCCEEE | 37.57 | 27667366 | |
| 8 (in isoform 2) | Ubiquitination | - | 37.57 | - | |
| 9 | Phosphorylation | SGGKYVDSEGHLYTV CCCCEECCCCCEEEE | 35.12 | 26824392 | |
| 11 (in isoform 2) | Phosphorylation | - | 21.76 | 29514104 | |
| 14 | Phosphorylation | VDSEGHLYTVPIREQ ECCCCCEEEEEEHHC | 10.46 | 16943184 | |
| 15 | Phosphorylation | DSEGHLYTVPIREQG CCCCCEEEEEEHHCC | 26.60 | 22499769 | |
| 16 (in isoform 2) | Ubiquitination | - | 2.04 | - | |
| 25 | Phosphorylation | IREQGNIYKPNNKAM EHHCCCEECCCCCCC | 25.13 | 23684622 | |
| 26 | Ubiquitination | REQGNIYKPNNKAMA HHCCCEECCCCCCCC | 37.16 | 22790023 | |
| 26 (in isoform 2) | Ubiquitination | - | 37.16 | - | |
| 30 | Ubiquitination | NIYKPNNKAMADEVT CEECCCCCCCCCCCC | 46.29 | 22790023 | |
| 37 | Phosphorylation | KAMADEVTEKQVYDA CCCCCCCCHHHHHHH | 35.10 | 23737553 | |
| 39 | Acetylation | MADEVTEKQVYDAHT CCCCCCHHHHHHHCC | 35.38 | 23806337 | |
| 39 | Succinylation | MADEVTEKQVYDAHT CCCCCCHHHHHHHCC | 35.38 | 23806337 | |
| 39 (in isoform 2) | Ubiquitination | - | 35.38 | 22790023 | |
| 39 | Ubiquitination | MADEVTEKQVYDAHT CCCCCCHHHHHHHCC | 35.38 | 27667366 | |
| 42 | Phosphorylation | EVTEKQVYDAHTKEI CCCHHHHHHHCCCEE | 12.62 | 21454597 | |
| 46 | Phosphorylation | KQVYDAHTKEIDLVN HHHHHHCCCEEECCC | 31.90 | 21454597 | |
| 47 (in isoform 2) | Ubiquitination | - | 42.69 | 22790023 | |
| 47 | Ubiquitination | QVYDAHTKEIDLVNR HHHHHCCCEEECCCC | 42.69 | 22790023 | |
| 57 | Ubiquitination | DLVNRDPKHLNDDVV ECCCCCCCCCCCCEE | 66.08 | 22790023 | |
| 57 (in isoform 2) | Ubiquitination | - | 66.08 | 22790023 | |
| 133 | S-palmitoylation | HIWAVVPCIKSFLIE HHHHHHHHHHHHHHH | 4.06 | - | |
| 143 | S-palmitoylation | SFLIEIQCISRVYSI HHHHHHHHHHCHHHH | 3.61 | - | |
| 156 | S-palmitoylation | SIYVHTFCDPLFEAI HHHHHHHCHHHHHHH | 5.75 | 28526873 | |
| 176 | Ubiquitination | NIRISTQKEI----- HCCEECCCCC----- | 58.42 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 14 | Y | Phosphorylation | Kinase | ABL1 | P00520 | Uniprot |
| 14 | Y | Phosphorylation | Kinase | INSR | P15208 | Uniprot |
| 14 | Y | Phosphorylation | Kinase | SRC | P05480 | PSP |
| 14 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
| 14 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CAV1_MOUSE !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CAV1_MOUSE !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FLOT1_MOUSE | Flot1 | physical | 12036959 | |
| INSR_MOUSE | Insr | physical | 12036959 | |
| STML3_MOUSE | Stoml3 | physical | 12122055 | |
| ADCY3_MOUSE | Adcy3 | physical | 12122055 | |
| JAK2_MOUSE | Jak2 | physical | 12388746 | |
| PPARG_MOUSE | Pparg | physical | 15164767 | |
| TRPC4_MOUSE | Trpc4 | physical | 17416589 | |
| ITPR3_MOUSE | Itpr3 | physical | 17416589 | |
| NF1_MOUSE | Nf1 | physical | 16405917 | |
| PRKN_MOUSE | Park2 | physical | 26627850 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-14, AND MASSSPECTROMETRY. | |
| "c-Abl is required for oxidative stress-induced phosphorylation ofcaveolin-1 on tyrosine 14."; Sanguinetti A.R., Mastick C.C.; Cell. Signal. 15:289-298(2003). Cited for: PHOSPHORYLATION AT TYR-14. | |
| "The insulin receptor catalyzes the tyrosine phosphorylation ofcaveolin-1."; Kimura A., Mora S., Shigematsu S., Pessin J.E., Saltiel A.R.; J. Biol. Chem. 277:30153-30158(2002). Cited for: PHOSPHORYLATION AT TYR-14. | |